Rate of development of resistance in Staphylococcus aureus to erythromycin in combination with oleandomycin, vancomycin, or dihydrostreptomycin.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000904:Antibiotics, Antitubercular; D001669:Biochemical Phenomena; D003879:Dermatologic Agents; D004096:Dihydrostreptomycin Sulfate; D004917:Erythromycin; D006801:Humans; D009827:Oleandomycin; D013203:Staphylococcal Infections; D013210:Staphylococcus / Q000494:pharmacology*; D013211:Staphylococcus aureus; D014640:Vancomycin
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D004917:Erythromycin; D014640:Vancomycin; D009827:Oleandomycin; D004096:Dihydrostreptomycin Sulfate
ANTIBIOTICS/pharmacology; STAPHYLOCOCCUS/pharmacology